271 related articles for article (PubMed ID: 30800128)
1. PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185
Nagai Y; Ji MQ; Zhu F; Xiao Y; Tanaka Y; Kambayashi T; Fujimoto S; Goldberg MM; Zhang H; Li B; Ohtani T; Greene MI
Front Immunol; 2019; 10():174. PubMed ID: 30800128
[TBL] [Abstract][Full Text] [Related]
2. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
[TBL] [Abstract][Full Text] [Related]
3. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
[TBL] [Abstract][Full Text] [Related]
4. Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity.
Wang L; Liu Y; Beier UH; Han R; Bhatti TR; Akimova T; Hancock WW
Blood; 2013 May; 121(18):3631-9. PubMed ID: 23444399
[TBL] [Abstract][Full Text] [Related]
5. PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.
Goel PN; Grover P; Greene MI
Crit Rev Immunol; 2020; 40(4):283-295. PubMed ID: 33426818
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
7. Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.
Du T; Nagai Y; Xiao Y; Greene MI; Zhang H
Exp Mol Pathol; 2013 Aug; 95(1):38-45. PubMed ID: 23644046
[TBL] [Abstract][Full Text] [Related]
8. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
9. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
10. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
[TBL] [Abstract][Full Text] [Related]
11. Protein Arginine Methyltransferase 5 Inhibition Upregulates Foxp3
Zheng Y; Huang L; Ge W; Yang M; Ma Y; Xie G; Wang W; Bian B; Li L; Nie H; Shen L
Front Immunol; 2017; 8():596. PubMed ID: 28588584
[TBL] [Abstract][Full Text] [Related]
12. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells.
Kawashima H; Takatori H; Suzuki K; Iwata A; Yokota M; Suto A; Minamino T; Hirose K; Nakajima H
J Immunol; 2013 Oct; 191(7):3614-23. PubMed ID: 24006461
[TBL] [Abstract][Full Text] [Related]
15. PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling.
Tanaka Y; Nagai Y; Okumura M; Greene MI; Kambayashi T
Front Immunol; 2020; 11():621. PubMed ID: 32328070
[TBL] [Abstract][Full Text] [Related]
16. Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity.
Chang X; Zheng P; Liu Y
J Immunol; 2008 Aug; 181(4):2399-406. PubMed ID: 18684929
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
18. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
Knutson KL; Dang Y; Lu H; Lukas J; Almand B; Gad E; Azeke E; Disis ML
J Immunol; 2006 Jul; 177(1):84-91. PubMed ID: 16785502
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity.
Wang L; Kumar S; Dahiya S; Wang F; Wu J; Newick K; Han R; Samanta A; Beier UH; Akimova T; Bhatti TR; Nicholson B; Kodrasov MP; Agarwal S; Sterner DE; Gu W; Weinstock J; Butt TR; Albelda SM; Hancock WW
EBioMedicine; 2016 Nov; 13():99-112. PubMed ID: 27769803
[TBL] [Abstract][Full Text] [Related]
20. Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.
Kurose K; Ohue Y; Wada H; Iida S; Ishida T; Kojima T; Doi T; Suzuki S; Isobe M; Funakoshi T; Kakimi K; Nishikawa H; Udono H; Oka M; Ueda R; Nakayama E
Clin Cancer Res; 2015 Oct; 21(19):4327-36. PubMed ID: 26429981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
